| Primary |
| Hypertension |
84.9% |
| Blood Pressure |
1.6% |
| Diabetes Mellitus |
1.5% |
| Oedema |
1.0% |
| Atrial Fibrillation |
0.9% |
| Cardiac Failure |
0.9% |
| Cardiac Failure Congestive |
0.8% |
| Coronary Artery Disease |
0.8% |
| Blood Pressure Management |
0.8% |
| Depression |
0.8% |
| Hyperlipidaemia |
0.8% |
| Blood Cholesterol |
0.7% |
| Urinary Tract Infection |
0.7% |
| Blood Pressure Abnormal |
0.6% |
| Cardiovascular Disorder |
0.6% |
| Convulsion |
0.6% |
| Type 2 Diabetes Mellitus |
0.6% |
| Blood Pressure Increased |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Insomnia |
0.5% |
|
| Angioedema |
9.0% |
| Blood Pressure Increased |
8.7% |
| Hypertension |
7.9% |
| Dizziness |
6.7% |
| Rash |
6.2% |
| Blood Pressure Inadequately Controlled |
6.1% |
| Oedema Peripheral |
6.0% |
| Drug Ineffective |
5.8% |
| Diarrhoea |
4.7% |
| Headache |
4.5% |
| Hypotension |
4.5% |
| Swelling Face |
4.1% |
| Renal Failure |
3.8% |
| Renal Failure Acute |
3.8% |
| Nausea |
3.6% |
| Somnolence |
3.1% |
| Swollen Tongue |
3.1% |
| Cough |
2.9% |
| Cerebrovascular Accident |
2.7% |
| Hyperkalaemia |
2.7% |
|
| Secondary |
| Hypertension |
50.3% |
| Drug Use For Unknown Indication |
9.1% |
| Product Used For Unknown Indication |
5.8% |
| Blood Pressure |
3.9% |
| Anxiety |
3.7% |
| Back Pain |
3.3% |
| Cardiac Failure |
3.1% |
| Diabetes Mellitus |
2.7% |
| Depression |
2.1% |
| Blood Cholesterol |
1.7% |
| Diabetic Nephropathy |
1.7% |
| Prophylaxis |
1.7% |
| Hyperlipidaemia |
1.5% |
| Pain |
1.5% |
| Asthma |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Cardiovascular Disorder |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypersensitivity |
1.3% |
| Essential Hypertension |
1.2% |
|
| Cerebrovascular Accident |
14.4% |
| Hypertension |
7.6% |
| Vision Blurred |
7.6% |
| Swelling |
6.8% |
| Blood Pressure Increased |
5.3% |
| Renal Disorder |
5.3% |
| Weight Decreased |
5.3% |
| Somnolence |
4.5% |
| Blood Pressure Inadequately Controlled |
3.8% |
| Diarrhoea |
3.8% |
| Headache |
3.8% |
| Oedema Peripheral |
3.8% |
| Pharyngeal Oedema |
3.8% |
| Renal Failure |
3.8% |
| Renal Failure Acute |
3.8% |
| Vomiting |
3.8% |
| Weight Increased |
3.8% |
| Blood Creatinine Increased |
3.0% |
| Blood Sodium Decreased |
3.0% |
| Drug Ineffective |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.6% |
| Drug Use For Unknown Indication |
25.5% |
| Hypertension |
17.5% |
| Blood Pressure |
3.1% |
| Blood Cholesterol Increased |
3.0% |
| Atrial Fibrillation |
2.6% |
| Diabetes Mellitus |
2.2% |
| Rheumatoid Arthritis |
1.9% |
| Pain |
1.9% |
| Osteoporosis |
1.7% |
| Prophylaxis |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Cardiac Disorder |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Blood Triglycerides Increased |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Blood Cholesterol |
1.1% |
| High Density Lipoprotein Decreased |
1.1% |
| Depression |
0.8% |
| Asthma |
0.8% |
|
| Drug Ineffective |
14.2% |
| Flushing |
9.7% |
| Pruritus |
7.5% |
| Headache |
5.3% |
| Vision Blurred |
5.3% |
| Vomiting |
4.9% |
| Weight Decreased |
4.9% |
| Dyspnoea |
4.4% |
| Nausea |
4.4% |
| Pain In Extremity |
4.4% |
| Weight Increased |
4.4% |
| Fatigue |
3.5% |
| Injection Site Pain |
3.5% |
| Pain |
3.5% |
| Paraesthesia |
3.5% |
| Rash |
3.5% |
| Visual Impairment |
3.5% |
| Arthralgia |
3.1% |
| Asthenia |
3.1% |
| Blood Glucose Increased |
3.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
73.3% |
| Convulsion |
13.3% |
| Blood Pressure Management |
6.7% |
| Supraventricular Tachycardia |
6.7% |
|
| Hypoacusis |
50.0% |
| Pollakiuria |
25.0% |
| Torsade De Pointes |
25.0% |
|
